Doxa AB

Equities

DOXA

SE0005624756

Real Estate Development & Operations

Market Closed - Nasdaq Stockholm Other stock markets 11:29:39 2024-05-17 am EDT			5-day change	1st Jan Change
2.625 ^SEK	+0.77%		-1.87%	-22.91%

Apr. 29	Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 10	Doxa AB announced that it has received SEK 200 million in funding	CI

Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024

April 29, 2024 at 07:00 am EDT

Doxa AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 4.8 million compared to SEK 1.1 million a year ago. Negative revenue was SEK 318.7 million compared to SEK 20.9 million a year ago.

Net loss was SEK 320.1 million compared to SEK 27.6 million a year ago. Basic loss per share from continuing operations was SEK 0.56 compared to SEK 0.09 a year ago. Diluted loss per share from continuing operations was SEK 0.56 compared to SEK 0.09 a year ago.

Latest news about Doxa AB

Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Doxa AB announced that it has received SEK 200 million in funding	Apr. 09	CI
Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Doxa AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Balder, Doxa Portfolio Company Sell Building Rights in Sweden for SEK1 Billion	Jan. 22	MT
Doxa AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-19	CI
Valsoia creates new market segment with first liquid vegetable egg	23-08-01	AN
Doxa AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-18	CI
Doxa AB (OM:DOXA) completed the acquisition of Serneke Group AB (OM:SRNKE B) from Ola Serneke Invest AB, Fastighets AB Balder (OM:BALD B), Svolder AB (OM:SVOL B) and other shareholders.	23-06-11	CI
When the narrative is stronger than fundamentals on stock markets	23-05-18
Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Serneke Receives Public Takeover Offer From Doxa	23-04-25	MT
Doxa AB (OM:DOXA) made an offer to acquire Serneke Group AB (OM:SRNKE B) from Ola Serneke Invest AB, Fastighets AB Balder (OM:BALD B), Svolder AB (OM:SVOL B) and other shareholders for SEK 1 billion.	23-04-23	CI
Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-15	CI
Doxa AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-15	CI
Lifco AB (OM:LIFCO B) acquired Doxa Dental Ab.	22-12-15	CI
Lifco Signs Deal to Buy Doxa Dental for Q1 2023 Consolidation	22-12-15	MT
Doxa AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-26	CI
Doxa AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-22	CI
Doxa AB (OM:DOXA) entered into agreement to acquire Retail property Stridsyxan 2 in Malmo from Swedish Logistic Property AB (OM:SLP B) for approximately SEK144 million.	22-05-18	CI
Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Doxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-09	CI
Doxa AB (OM : DOXA) acquired Sundsbron Fastighets AB from Brorman Fastigheter AB.	22-02-02	CI
Doxa AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-27	CI
Doxa AB Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-26	CI

Chart Doxa AB

Duration

Period

More charts

Company Profile

Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.

Sector

Real Estate Development & Operations

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Real Estate Development & Operations

	1st Jan change	Capi.
DOXA AB	-22.91%	142M
CHINA RESOURCES LAND LIMITED	+17.32%	29.15B
SUN HUNG KAI PROPERTIES LIMITED	-5.15%	27.94B
MITSUI FUDOSAN CO., LTD.	+26.23%	26.02B
DLF LIMITED	+16.84%	24.95B
MITSUBISHI ESTATE CO., LTD.	+40.97%	22.49B
CHINA OVERSEAS LAND & INVESTMENT LTD.	+20.06%	22.19B
EMAAR PROPERTIES	-4.42%	18.48B
POLY DEVELOPMENTS AND HOLDINGS GROUP CO., LTD.	+13.13%	16.73B
HENDERSON LAND DEVELOPMENT COMPANY LIMITED	+9.98%	16.19B

Other Real Estate Development & Operations